Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.29% to 10589.99, DAX +0.36% to 24154.47, CAC40 (0.14%) to 8262.70, STOXX 600 (0.05%) to 616.95

Apr 16 ,2026

  • Synopsis:

    • European equity markets mixed after moving off session highs. Media, chemicals, technology and retail the top performers. Travel/leisure, banks and utilities the main laggards. Follows mostly weaker performance on Wednesday, yet Stoxx 600 remains in positive territory on the week. Asian equity markets mostly higher, with Nikkei and Kospi outperforming amid tech strength. US equity markets higher in midday trading. German Bund yield down around 2 bps to ~3.02%, while the 10-year Italian BTP yield down 3 bps at 3.82%. Gilts 2 bps firmer. Dollar index up 0.2%. Gold down 0.4%. Silver 1.4% lower. Bitcoin futures off 0.1%. WTI crude up 2.5%

    • Iran conflict de-escalation signals continue to drive risk sentiment with latest headlines noting US and Iran have agreed in-principle to extend ceasefire beyond next week's deadline to allow more time for diplomacy. Second round of talks expected soon, likely in Pakistan again with VP Vance leading US delegation. Trump continues to voice confidence about deal, though press also noted US sending over thousands of additional troops to region in bid to pressure Iran into an agreement.

    • Lot of central bank commentary to digest in Europe. ECB source report said officials leaning towards keeping policy unchanged at the end of this month, as incoming data won't offer enough clarity on economic impact of Iran conflict. Both Schnabel and Villeroy signaled caution. March ECB minutes highlights need for evidence before acting on energy shock. BoE Governor Bailey reiterated that he is no rush to raise interest rates, reinforcing expectations of steady hand. SNB's Schlegel reiterated willingness to intervene in FX market with Swiss franc strengthening at the start of the Middle East conflict, though has since eased due to previous SNB warnings.

    • On the macro data front, final Eurozone CPI revised up from flash to 2.6% y/y versus 2.5%. UK monthly activity data for February, which saw economy expand 0.5% m/m before the Iran conflict started.

    • On a busy earnings front, several major companies have reported, including Tesco (TSCO.LN), EasyJet (EZJ.LN), Rentokil (RTO.LN), Barry Callebaut (BARN.SW), DocMorris (DOCM.SW), TomTom (TOM2.NA) and Pernod Ricard (RI.FP). Separately, Kering (KER.FP) outlined its new strategy at today's CMD. In other news, Gerresheimer (GXI.GR) received creditor support extending FY25 results to Sep-2026 and waiving covenants through Q3 2026, eliminating credit risk; progress on selling Centor and in-line 2026 trading reinforce the turnaround case despite audit delays. Banca Monte dei Paschi di Siena (BMPS.IM) is also higher following the election of a new board.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Media +1.54%, Technology +1.45%, Telecom +0.97%, Chemicals +0.81%, Oil & Gas +0.69%, Retail +0.68%, Construct & Mtls +0.46%, Basic Resources +0.28%, Financial Svcs +0.20%, Real Estate +0.08%, Insurance +0.00%, Food & Beverage (0.01%)

      • Underperformers:

        • Travel & Leisure (1.65%), Banks (0.98%), Utilities (0.86%), Autos & Parts (0.45%), Persnl & HHold Goods (0.44%), Health Care (0.36%), Ind Goods & Svcs (0.12%)

    • Macro:

      • Central Banks:

        • ECB likely to hold rates this month amid uncertainty over Iran war impact: Bloomberg

        • BoE Governor Bailey signals no April rate change: BBC

        • BoE to add AI risks into stress tests, lawmakers say: Bloomberg

      • Economy:

        • Eurozone consumer prices rise faster than expected in March, surpassing ECB's 2% target due to rising oil costs: Investing.com

        • EU prepares emergency plans to tackle jet fuel crunch from Iran war: Reuters

      • UK:

        • UK economy smashes forecasts with 0.5% growth in February (Guardian)

        • Chancellor Reeves to unveil £600M annual energy bill relief for UK manufacturers (Bloomberg)

        • UK mortgage rates start falling as swap markets ease post-Iran war shock (FT)

      • Germany:

        • Government halves 2026 growth forecast to 0.5% amid Iran war, source says: Reuters

    • Peripheral markets:

      • Spain:

        • Russia sends Spain its largest gas shipment in history during the first month of the war in the Middle East: ElPais

      • Switzerland

        • SNB minutes highlight monetary policy remains expansionary

        • Switzerland Seeking to Curb Foreign Home Buying Amid Shortages - Bloomberg

    • Company news:

      • Notable Gainers

        • +34.6% ANCR.LN (Animalcare Group £3.33, +0.86) -- Charterhouse Capital Partners makes recommended 336p/share in cash offer to acquire Animalcare Group

        • +17.7% GXI.GR (Gerresheimer €20.84, +3.14) -- creditors agree to extend due date for submitting financial statements

        • +13.9% SINCH.SS (Sinch SEK27.93, +3.43) -- Grizzly Research report

        • +10.9% CABP.LN (CAB Payments Holdings £0.97, +0.10) -- increased final possible offer from StoneX at 110p/sh; independent board signals willingness to recommend deal

        • +10.6% DUST.SS (Dustin Group SEK1.71, +0.16) -- Handelsbanken upgrade

        • +10.6% DOCM.SW (DocMorris CHF6.29, +0.61) -- Q1 Adj EBITDA (CHF6.3M) vs year-ago (CHF16.1M)

        • +10.6% ITRK.LN (Intertek Group £48.24, +4.61) -- acquires assets of state-of-the-art solar PV laboratory from Mitsui Chemicals India Pvt. Ltd.; terms undisclosed

        • +10.5% VRCI.LN (Verici Dx £0.01, -0.00) -- Q1 Tutivia testing volumes

        • +7.9% AVG.LN (Avingtrans £6.26, +0.46) -- orders update

        • +7.5% MGNS.LN (Morgan Sindall Group £48.20, +3.38) -- trading update; anticipates FY26 results to be significantly ahead of its previous expectations

        • +7.4% MFEB.IM (MFE-MEDIAFOREUROPE €3.91, +0.27) -- FY net income €300.7M vs FactSet €316.6M [6 est, €110.9-497.7M]

        • +7.2% INTEG.B.SS (Integrum SEK8.76, +0.59) -- treatment expansion

        • +6.7% PLNW.FP (Planisware €16.86, +1.06) -- Q1 revenue €51.0M vs FactSet €50.1M [2 est, €49.5-50.7M]

        • +6.3% ENT.LN (Entain £6.22, +0.37) -- Q1 Trading Update: Group Net Gaming Revenue +3% y/y; reaffirms FY26 guidance

        • +6.2% MERC.LN (Mercia Asset Management £0.30, +0.02) -- trading update

        • +6.0% CMCOM.NA (CM.com €6.04, +0.34) -- earnings

        • +5.9% AFK.NO (Arendals Fossekompani NOK187.00, +10.50) -- initiated buy at Danske Bank

        • +5.0% RSGN.SW (R&S Group Holding CHF26.04, +1.26) -- target up at Berenberg

        • +4.6% PFSE.GR (PFISTERER Holding €95.75, +4.25) -- target up at Berenberg, LBBW

        • +4.2% TSCO.LN (Tesco plc £4.92, +0.20) -- FY adj. EPS 29.0p vs consensus 28.6p; announces share buyback of £750M to be completed by Apr-27; ups medium-term FCF guidance range

        • +3.8% ALICA.FP (ICAPE Holding €5.48, +0.20) -- buyback mandate

        • +3.6% OLTH.GA (Thessaloniki Port Authority €37.80, +1.30) -- earnings

        • +3.2% CREO.LN (Creo Medical Group £0.12, -0.00) -- sell manufacturing operations to manufacturing operations management; terms undisclosed

        • +3.1% KESKOB.FH (Kesko €20.42, +0.61) -- March sales from continuing operations €1.18B, +12.2% in comparable terms

        • +3.0% PLX.FP (Pluxee €12.07, +0.35) -- H1 adj net income €116M vs FactSet €123M

        • +2.9% AKZA.NA (Akzo Nobel €52.40, +1.50) -- UK's CMA invites comments from interested parties regarding Akzo Nobel's acquisition of Axalta Coating Systems

        • +2.7% MB.IM (Mediobanca €19.71, +0.52) -- Banca Monte dei Paschi di Siena AGM elects new board of directors; PLT Holding's list wins -- Italian press

        • +2.7% FAST.NA (Fastned €24.40, +0.65) -- Q1 revenue related to charging €39.2M, +40% y/y; reaffirms FY guidance

        • +2.7% ARION.IR (Arion Banki ISK187.50, +5.00) -- Merger between Arion banki and Kvika banki will not take place

        • +2.4% BMPS.IM (Banca Monte dei Paschi di Siena €8.82, +0.21) -- Banca Monte dei Paschi di Siena AGM elects new board of directors; PLT Holding's list wins -- Italian press

        • +2.4% MTO.LN (Mitie Group £1.84, +0.04) -- FY Trading Update: revenue £5.65B vs FactSet £5.66B [8 est, £5.61-5.70B]; acquires two Fire & Security businesses for a combined initial cash consideration of £8.1M

        • +2.1% ALERS.FP (Eurobio-Scientific €24.40, +0.50) -- CareDx (CDNA) to Divest Lab Products Business to EuroBio Scientific for $170M and announces Q1 preliminary financial results

        • +2.1% CSG.NA (CSG NV €21.68, +0.44) -- contract

        • +2.1% NOVO.B.DC (Novo Nordisk DKK257.20, +5.35) -- Oral Wegovy weekly TRx +10.7% w/w

        • +2.1% MAU.FP (Maurel et Prom €9.60, +0.20) -- Q1 activity update: working interest production 37,444 boepd, +7% y/y

        • +2.0% HAS.LN (Hays Plc £0.33, +0.01) -- Q3 Trading Statement: LFL Net Fee Growth (8%) vs consensus (9%); continues to expect FY26 adj. operating profit in line with consensus

        • +0.6% TOM2.NA (TomTom €4.53, +0.03) -- reports Q1 adjusted net income €13.7M vs year-ago €3.0M

      • Notable Decliners

        • -29.1% CRNA.NO (Circio Holding NOK5.85, -2.40) -- reports FY25 EPS (NOK0.44) vs year-ago NOK2.79

        • -15.6% BARN.SW (Barry Callebaut CHF1,069.00, -197.00) -- H1 net income CHF108.9M ex-items vs FactSet CHF113.9M [2 est, CHF92.7-135M]; Updates FY25/26 outlook

        • -14.8% ALU.LN (Alumasc Group £2.22, -0.39) -- trading update

        • -11.2% HDD.GR (Heidelberger Druckmaschinen €1.56, -0.20) -- adjusts earnings forecast for 2025/2026 financial year

        • -8.5% BYS.SW (Bystronic CHF210.00, -19.50) -- sales

        • -7.9% PMI.LN (Premier Miton Group £0.41, -0.04) -- trading update

        • -5.7% EZJ.LN (EasyJet £3.69, -0.22) -- H1 Trading Update: Expects to report a headline loss before tax of between £540M and £560M for the period

        • -5.4% DNLM.LN (Dunelm Group £8.02, -0.46) -- trading update; reports Q3 sales growth of 2.1% ; FY26 PBT currently expected to be towards lower end of consensus expectations

        • -5.3% KOG.NO (Kongsberg Gruppen NOK376.10, -21.00) -- Nordea downgrade

        • -4.4% APN.LN (Applied Nutrition £2.17, -0.10) -- holder JD Sports Fashion to sell entire 22.8M-share stake at £2.15/share for gross proceeds ~£49M

        • -4.3% ASHM.LN (Ashmore Group £2.12, -0.10) -- Q3 AuM $50.7B vs prior quarter $52.5B

        • -3.7% MTRS.SS (Munters Group SEK191.35, -7.25) -- DNB Carnegie downgrade

        • -3.2% QLINEA.SS (Q-linea SEK21.00, -0.70) -- FDA clearance

        • -3.1% EDP.PL (EDP-Energias de Portugal €4.53, -0.15) -- BofA downgrade

        • -3.1% AIXA.GR (Aixtron €41.03, -1.32) -- convertible bonds offering

        • -2.8% SLIGR.NA (Sligro Food Group €13.04, -0.38) -- Trading Update: reports Q1 revenue €578M vs year-ago €574M

        • -2.3% KER.FP (Kering €248.05, -5.95) -- presents ReconKering strategy at CMD: targets mid-term to more than double full-year 2025 recurring operating margin percentage at Group level

        • -2.3% BO.DC (Bang & Olufsen DKK8.95, -0.21) -- Q3 revenue DKK621M vs FactSet DKK621.0M [2 est, DKK621-621M]

        • -2.0% FARN.LN (Faron Pharmaceuticals £0.44, -0.01) -- trial collaboration

        • -1.7% BFIT.NA (Basic-Fit €33.54, -0.58) -- Q1 revenue €396M vs FactSet €398.0M [1 est]; raises FY underlying EBITDA by €10M €415M - €455M

        • -1.7% KOF.FP (Kaufman & Broad €28.50, -0.50) -- Q1 net income €11.8M vs FactSet €11.7M [1 est]

        • -1.7% NSI.NA (NSI NV €17.64, -0.30) -- Q1 Trading update; EPRA EPS €0.35 vs year-ago €0.42

        • -1.5% VACN.SW (VAT Group CHF555.60, -8.40) -- Q1 revenue CHF220.9M vs FactSet CHF217.5M [2 est, CHF215-220M]

        • -1.3% SAGA.B.SS (Sagax SEK190.20, -2.60) -- adjusts financial targets: expects return on equity of at least 12% per year over the period 2026-2030

        • -1.2% OGI.CN (OrganiGram C$2.09, -0.02) -- completes Sanity Group acquisition

        • -1.1% BF.B (Brown-Forman $29.30, -0.32) -- Sazerac's offer for Brown-Forman was for $32/sh - media report

        • -1.0% RTO.LN (Rentokil Initial £4.96, -0.05) -- Q1 revenue $1.68B, +8% vs year-ago $1.56B

    • EU companies reporting tomorrow:

      • Earnings:

        • Nordics: Telefonaktiebolaget LM Ericsson (ERIC.B.SS), Nederman Holding (NMAN.SS), Byggmax Group (BMAX.SS)

        • Southern Europe: Ellaktor (ELLAKTOR.GA), Seri Industrial (SERI.IM)

  • Data:

    • Economics:

      • Eurozone Mar CPI +2.6% y/y vs prelim +2.5%; +1.3% m/m vs prelim +1.2%

        • Mar core CPI +2.3% y/y vs prelim +2.3%

      • UK Feb

        • Visible Trade Balance (£18.79B) vs cons (£20.2B) and prior revised (£15.08B) from (£14.45B)

          • Trade Balance (£0.72B) vs cons (£3.6B) and prior revised £3.02B from £3.92B

        • Construction Output (1.0%) y/y vs cons (0.5%) and prior revised (1.9%) from (0.2%)

        • Industrial Production (0.4%) y/y vs cons (0.9%) and prior revised +0.5% from +0.4%; +0.5% m/m vs cons +0.2% and prior (0.1%)

        • Manufacturing Production (0.5%) y/y vs cons (0.3%) and prior +1.3%; (0.1%) m/m vs cons +0.3% and prior revised +0.2% from +0.1%

      • Italy Mar CPI +1.7% y/y vs prelim +1.7%; +0.5% m/m vs prelim +0.5%

        • EU Harmonised: +1.6% y/y vs prelim +1.5%; +1.7% m/m vs prelim +1.6%

      • Austria Mar CPI +3.2% y/y vs prelim +3.1%; +1.2% m/m vs prelim +1.1%

        • EU Harmonised: +3.1% y/y vs prelim +3.1%

      • Switzerland Mar PPI (2.7%) y/y vs prior (2.7%); +0.2% m/m vs cons +0.5% and prior (0.3%)

      • Netherlands Mar Unemployment Rate 4.0% vs cons 4.1% and prior 4.1%

    • Markets:

      • WTI Crude (May 26): +$2.39 or +2.62% to $93.68

      • €-$ (0.0023) or (0.19%) to 1.1778

      • £-$ (0.0030) or (0.22%) to 1.3533

      • €-£ +0.0001 to 0.8703

      • S&P 500 +0.20%

      • Performance year-to-date

        • FTSE 100: +6.63%

        • DAX: (1.37%)

        • CAC: +1.39%

        • MIB: +6.86%

        • Stoxx 600: +4.18%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.